Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2007
04/12/2007US20070082919 Process for Preparing a Co-Precipitate of a Non-Crystalline Solid Drug Substance
04/12/2007US20070082897 Acylated indanyl amines and their use as pharmaceuticals
04/12/2007US20070082857 combination of an aminoglycoside antibiotic such as tobramycin or gentamicin, bromfenac as a nonsteroidal antiinflammatory agent and nicotinamide; an eye drop, nose drop or an injection; no side effects; no precipitation even after preservation
04/12/2007US20070082855 Pharmaceutical formulations employing short-chain sphingolipids and their use
04/12/2007US20070082075 Traditional chinese medicine preparation for treatment of tumor and method of making and using same
04/12/2007US20070082055 Stable micronized candesartan cilexetil and methods for preparing thereof
04/12/2007US20070082054 Particle size reduction of bioactive compounds
04/12/2007US20070082053 Solid dispersions of opioid antagonists
04/12/2007US20070082052 Tympanic membrane repair constructs
04/12/2007US20070082051 Modified Release Formulations of Antihypertensive Drugs
04/12/2007US20070082050 Modified release formulations of antihypertensive drugs
04/12/2007US20070082049 Extended release venlafaxine tablet formulation
04/12/2007US20070082048 Sleep aid formulations
04/12/2007US20070082047 Solid preparation
04/12/2007US20070082046 Enteric valproic acid
04/12/2007US20070082045 Seamless capsule manufacturing method, seamless capsule manufacturing device and seamless capsule
04/12/2007US20070082044 Synergistic effect of compositions comprising carotenoids selected from lutein, beta-carotene and lycopene
04/12/2007US20070082043 Liposomal vaccine
04/12/2007US20070082042 Multiple-layered liposome and preparation method thereof
04/12/2007US20070082041 Topical delivery of codrugs
04/12/2007US20070082040 Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
04/12/2007US20070082039 Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids, the use of the same as percutaneous permeation enhancers, and topical gels for the transdermal delivery of steroids
04/12/2007US20070082038 Transdermal nicotine salt delivery system
04/12/2007US20070082037 Transdermal preparations and method for relieving side effects in pergolide therapy
04/12/2007US20070082034 Dual-sided cleansing wipes for medical equipment
04/12/2007US20070082033 Substrate containing lipids
04/12/2007US20070082032 Skin care pad
04/12/2007US20070082018 Stabilized antimicrobial compositions and related methods of preparation
04/12/2007US20070082017 Lipid compositions and methods of use
04/12/2007US20070082016 Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amide renin inhibitor in absorption enhancing carrier comprising lipophilic component, high HLB surfactant, hydrophilic component, which on mixing forms stable microemulsion concentrate; bioavailability; side effect reduction; cardiovascular disorders
04/12/2007US20070082010 Urogenital or anorectal transmucosal vaccine delivery system
04/12/2007US20070081977 Device for transdermal administration of active substances
04/12/2007US20070081972 Polymer-based delivery system for immunotherapy of cancer
04/12/2007US20070081971 Non-glycosylated G-CSF capable of beneficially stabilizing G-CSF without the addition of surfactants and additives derived from human and/or animal origin; long shelf life, physiologically well-tolerated, simple to use and it is possible to dose it precisely
04/12/2007US20070081963 Composition for improving skin conditions comprising human growth hormone as an active ingredient
04/12/2007US20070081960 With collagen and a polysaccharide such as hydroxyethyl starch as stabilizer; reduced toxicity and/or a reduced immunogenicity
04/12/2007US20070081950 Solid oral tooth whitening confectionary composition
04/12/2007US20070081949 Buccal drug delivery
04/12/2007US20070081948 Dry powder composition comprising a benzodiazepine for pulmonary inhalation
04/12/2007US20070081947 Solid active ingredient formulation
04/12/2007US20070080323 Compositions of lipids and cationic peptieds
04/12/2007DE102005049001A1 Verfahren zur Herstellung von direkttablettierbaren Ibuprofen-Formulierungen A process for the production of direct-tabletable ibuprofen formulations
04/12/2007DE102005048741A1 Material, useful for the preparation of two-dimensional laminar and three-dimensional structural, purely biological products, comprises a processing product e.g. pumpkin filler, pumpkin binder (glue) or pumpkin juice from Cucurbitaceae
04/12/2007CA2624568A1 Oligouronate treatment
04/12/2007CA2624503A1 Solid vaccine formulation
04/12/2007CA2624362A1 Liposomes comprising collagen and their use in improved skin care
04/12/2007CA2624306A1 Solid pharmaceutical dosage forms which can be adminstered orally and have rapid release of active ingredient
04/12/2007CA2624170A1 Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
04/12/2007CA2624122A1 Oral composition containing a salivation inducing agent
04/12/2007CA2624111A1 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis
04/12/2007CA2624088A1 Sustained release small molecule drug formulation
04/12/2007CA2624050A1 Pharmaceutical compositions stabilized in glassy particles
04/12/2007CA2623848A1 Topical anesthetic for dental procedures
04/12/2007CA2623237A1 Novel dosage formulation
04/12/2007CA2623201A1 Pharmaceutical preparation containing meloxicam
04/12/2007CA2623031A1 Antifungal composition
04/12/2007CA2623011A1 New formulation
04/12/2007CA2622822A1 Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof
04/12/2007CA2622193A1 Antibiotic formulations, unit doses, kits, and methods
04/12/2007CA2621152A1 Pharmaceutical compositions of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto
04/12/2007CA2609953A1 Saccharide foamable compositions
04/11/2007EP1772767A2 Method for forming contact lenses comprising therapeutic agents
04/11/2007EP1772186A1 Process for producing nanoparticle or nanostructure with use of nanoporous material
04/11/2007EP1772156A1 Liposome-containing x-ray radiopaque dye and process for producing the same
04/11/2007EP1772150A1 Benzothiophene formulations of a specific dosage
04/11/2007EP1772142A2 Organic compounds
04/11/2007EP1772141A1 Method for effecting solid state crystallization
04/11/2007EP1771476A2 Crystallization of antibodies or fragments thereof
04/11/2007EP1771202A2 Methods of modulating intracellular degradation rates of toxins
04/11/2007EP1771199A1 Long-acting colloidal insulin formulation and preparation thereof
04/11/2007EP1771184A2 Calcium phosphate cements and methods for using the same
04/11/2007EP1771180A1 Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase
04/11/2007EP1771161A1 Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form
04/11/2007EP1771160A2 Alcohol resistant dosage forms
04/11/2007EP1771159A1 Sustained-release preparations containing topiramate and the producing method thereof
04/11/2007EP1771158A1 Tablet for pulsed delivery
04/11/2007EP1771157A1 Multiparticle pharmaceutical dosage form for low-soluble active substances and method for producing said pharmaceutical dosage form
04/11/2007EP1771156A1 Sterol enriched mixed lamellarity amphotericin intercalating liposomes in saline and the process for their preparation
04/11/2007EP1771155A2 Method and composition for treating rhinitis
04/11/2007EP1771154A1 Galenic applications of self-emulsifying mixtures of lipidic excipients
04/11/2007EP1771153A1 Composition for delivery of an active agent
04/11/2007EP1771133A1 Coated vaginal device for delivery of anti-migraine and anti-nausea drugs and a method for treatment of migraine and nausea
04/11/2007EP1633325B1 Oil emulsion for postnatal hormone substitution
04/11/2007EP1587501A4 Simple tablet compression using gelatin
04/11/2007EP1578422B1 A physically and chemically stable nicotine and micorcrystalline cellulose containing particulate material
04/11/2007EP1474159B1 Compositions containing oat straw and willowherb extract
04/11/2007EP1435985B1 Medicament containing activated antithrombin iii
04/11/2007EP1414458B1 Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
04/11/2007EP1368090B1 Apparatus for dispensing powdered material
04/11/2007EP1353952B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
04/11/2007EP1342462B1 O/w emulsion composition and method of preparing the same
04/11/2007EP1300143B1 Patch containing 4-biphenylacetic acid
04/11/2007EP1272177B1 Method and formulation for treating resistance to antihypertensives and related conditions
04/11/2007EP1263416B1 Compressed microparticles for dry injection
04/11/2007EP1239884B1 Methods for preparing pharmaceutical formulations
04/11/2007EP1207868B1 Pharmaceutical tramadol salts
04/11/2007EP1014944B1 Biocompatible compounds for pharmaceutical drug delivery systems
04/11/2007CN2887309Y Microcapsule of timulin fumarate
04/11/2007CN2887307Y Milling type cataplasma forming apparatus
04/11/2007CN1946904A Paper tissue with high lotion transferability